Mild to Moderate Alzheimer's
A research study for a potential new treatment for Alzheimer’s disease is looking for qualified people to enroll:
​
For ages 50 to 85
​
Have a diagnosis of mild AD dementia, OR a diagnosis of mild cognitive impairment (MCI) due to AD, OR memory concerns noticed by another person.
​
Have a study partner who can come with you to some visits and take part in some testing.
​
There is no cost to you to participate and insurance is not required.
Those eligible can earn up to $2,350.00
Type 2 Diabetes with Inadequate Glycemic Control
If you have type 2 diabetes, struggle with weight loss, and have inadequate glycemic control, you may be eligible for this study.
​​​
For ages 18 and older
​
Must have Type 2 Diabetes
Inadequate Glycemic Control with Metformin with or without SGLT2 Inhibitor.
​
There is no cost to you to participate and insurance is not required.
Those eligible can earn up to $3,360.00
*For those who qualify, transportation will be reimbursed at least the minimum standard IRS medical mileage rate*
Mild Cognitive Impairment
We are looking for people who have been diagnosed with mild cognitive impairment and are interested in participating in a clinical trial.
​​
For ages 50 to 85
​
Must have a diagnosis of Mild Cognitive Impairment or Dementia
​​​
There is no cost to you to participate and insurance is not required.
Those eligible can earn up to $2,350.00
Type 2 Diabetes with Renal Impairment
If you have type 2 diabetes, struggle with weight loss, and have moderate to severe renal impairment, you may be eligible for this study.
​​​
For ages 18 and older
​
Must have Type 2 Diabetes
Moderate or Severe Renal Impairment with Inadequate Glycemic Control on Basal Insulin with or without Metformin and/or SGLT2 inhibitor.
​
There is no cost to you to participate and insurance is not required.
Those eligible can earn up to $4,500.00
*For those who qualify, transportation will be reimbursed at least the minimum standard IRS medical mileage rate*
Obsessive Compulsive Disorder
If you suffer from obsessive-compulsive disorder (OCD), a clinical trial may be able to help. We are studying an investigational drug to help treat the symptoms of OCD.
For ages 18 to 65
Diagnosis of Obsessive Compulsive Disorder
Currently on a stable dose of an SSRI
​
There is no cost to you to participate and insurance is not required.
​
Those eligible can earn up to $1,250.00
Fragile X Syndrome
The purpose of this study is to assess the effectiveness and safety of an investigational treatment for individuals with Fragile X syndrome (FXS).
​
For ages 3 to 29
Diagnosis of Fragile X Syndrome
​
There is no cost to you to participate and insurance is not required.
​
Therapeutic Areas of Interest
Considering:
​
Gastrointestinal
Weight Loss
Anxiety
Substance Abuse
​​
Please check back often to see if any new studies have been added.